Cargando…

Identification of Disease-Associated Variants by Targeted Gene Panel Resequencing in Parkinson's Disease

Background: Recent advanced technologies, such as high-throughput sequencing, have enabled the identification of a broad spectrum of variants. Using targeted-gene-panel resequencing for Parkinson's disease (PD)-associated genes, we have occasionally found several single-nucleotide variants (SNV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daida, Kensuke, Funayama, Manabu, Li, Yuanzhe, Yoshino, Hiroyo, Hayashida, Arisa, Ikeda, Aya, Ogaki, Kotaro, Nishioka, Kenya, Hattori, Nobutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550729/ https://www.ncbi.nlm.nih.gov/pubmed/33117265 http://dx.doi.org/10.3389/fneur.2020.576465

Ejemplares similares

A complex form of hereditary spastic paraplegia harboring a novel variant, p.W1515*, in the SPG11 gene
por: Daida, Kensuke, et al.
Publicado: (2022)

Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies
por: Nishioka, Kenya, et al.
Publicado: (2022)

Molecular genetics of Parkinson’s disease: Contributions and global trends
por: Funayama, Manabu, et al.
Publicado: (2022)

Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features
por: Ikeda, Aya, et al.
Publicado: (2019)

A Novel LRRK2 Variant p.G2294R in the WD40 Domain Identified in Familial Parkinson’s Disease Affects LRRK2 Protein Levels
por: Ogata, Jun, et al.
Publicado: (2021)

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
por: Tezuka, Toshiki, et al.
Publicado: (2022)

Long-read sequencing resolves a complex structural variant in PRKN Parkinson’s disease
por: Daida, Kensuke, et al.
Publicado: (2023)

α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property
por: Daida, Kensuke, et al.
Publicado: (2022)

Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations
por: Takanashi, Masashi, et al.
Publicado: (2018)

CSF1R Mutation p.G589R and the Distribution Pattern of Brain Calcification
por: Daida, Kensuke, et al.
Publicado: (2017)

Somnolence Preceded the Development of a Subthalamic Lesion in Neuromyelitis Optica Spectrum Disorder
por: Daida, Kensuke, et al.
Publicado: (2019)

Radiation-induced Brain Calcification Leads to L-dopa-resistant Parkinsonism and Cerebellar Ataxia
por: Shimada, Tomoyo, et al.
Publicado: (2022)

Parkinsonism Relating to Intoxication with Glyphosate
por: Eriguchi, Makoto, et al.
Publicado: (2019)

Unclassified four-repeat tauopathy associated with familial parkinsonism and progressive respiratory failure
por: Nakano, Masayoshi, et al.
Publicado: (2020)

New-onset Refractory Status Epilepticus Involving the Limbic System, Spinal Cord, and Peripheral Nerves
por: Daida, Kensuke, et al.
Publicado: (2019)

ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout
por: Matsuo, Hirotaka, et al.
Publicado: (2015)

Marked Reduction in the Striatal Dopamine Transporter Uptake During the Early Stage of Motor Symptoms in Patients with the MAPT N279K Mutation
por: Takeshige, Haruka, et al.
Publicado: (2018)

Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy
por: Lin, Chin-Hsien, et al.
Publicado: (2020)

The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson’s disease
por: Tanaka, Ryota, et al.
Publicado: (2020)

Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease
por: Yamaguchi, Akihiro, et al.
Publicado: (2020)

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
por: Fujimaki, Motoki, et al.
Publicado: (2018)

A metabolic profile of polyamines in parkinson disease: A promising biomarker
por: Saiki, Shinji, et al.
Publicado: (2019)

Brain White-Matter Degeneration Due to Aging and Parkinson Disease as Revealed by Double Diffusion Encoding
por: Kamiya, Kouhei, et al.
Publicado: (2020)

Parkinson’s disease: deep learning with a parameter-weighted structural connectome matrix for diagnosis and neural circuit disorder investigation
por: Yasaka, Koichiro, et al.
Publicado: (2021)

Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson’s disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group study (CONST-PD)
por: Hatano, Taku, et al.
Publicado: (2022)

Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c
por: Meng, Hongrui, et al.
Publicado: (2017)

Shared Metabolic Profile of Caffeine in Parkinsonian Disorders
por: Takeshige‐Amano, Haruka, et al.
Publicado: (2020)

Nonmotor Symptoms in Patients with PARK2 Mutations
por: Yoritaka, Asako, et al.
Publicado: (2011)

Detection of genomic rearrangements from targeted resequencing data in Parkinson's disease patients
por: Spataro, Nino, et al.
Publicado: (2016)

New Lung Cancer Panel for High-Throughput Targeted Resequencing
por: Kim, Eun-Hye, et al.
Publicado: (2014)

MR Biomarkers of Degenerative Brain Disorders Derived From Diffusion Imaging
por: Andica, Christina, et al.
Publicado: (2019)

Genetic Mutations and Mitochondrial Toxins Shed New Light on the Pathogenesis of Parkinson's Disease
por: Sato, Shigeto, et al.
Publicado: (2011)

Cytomegalovirus-associated encephalomyelitis in an immunocompetent adult: a two-stage attack of direct viral and delayed immune-mediated invasions. case report
por: Daida, Kensuke, et al.
Publicado: (2016)

Istradefylline for Restless Legs Syndrome Associated with Parkinson’s Disease
por: Nuermaimaiti, Maierdanjiang, et al.
Publicado: (2018)

Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation
por: Ogawa, Takashi, et al.
Publicado: (2018)

Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
por: Iseki, Tatou, et al.
Publicado: (2023)

MDSGene: Closing Data Gaps in Genotype-Phenotype Correlations of Monogenic Parkinson’s Disease
por: Klein, Christine, et al.
Publicado: (2018)

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
por: Mori, Akio, et al.
Publicado: (2020)

LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias
por: Johansen, Christopher T., et al.
Publicado: (2014)

Advanced diffusion magnetic resonance imaging in patients with Alzheimer's and Parkinson's diseases
por: Kamagata, Koji, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2u3ihq8v98pouo9h4eoml4mqm9